Latest Exploration News

Imugene Limited reports durable patient responses in multiple cancer immunotherapy trials and strengthens its financial position with a $46 million convertible note deal and a substantial R&D tax refund.

Sunshine Metals Ltd reports a substantial upgrade to its Ravenswood Consolidated Project, with a 57% rise in contained gold and positive drilling and metallurgical results underpinning the growth.

FAR Limited has been notified by Woodside Energy of a potential claim linked to a Senegal Ministry audit disputing past petroleum expenditure, possibly triggering a $6.8 million indemnity under their 2021 sale agreement.

Vulcan Energy Resources reported a robust cash position of €97 million at the end of 2024 despite significant cash outflows driven by exploration and development activities. The company’s strong liquidity is supported by unused financing facilities, positioning it well for upcoming operational demands.

Centrex Limited stabilises operations at Ardmore Mine, completes Australia’s first phosphate export to India, and launches a $10.4 million entitlement offer to fund expansion.

Lakes Blue Energy reported a $1.5 million quarterly operational spend and completed the $6.5 million sale of its 49% interest in PEP 169, while progressing drilling approvals for the Wombat-5 well in Victoria.

Torque Metals delivers standout drilling results at its Paris Gold Project, confirming high-grade gold zones beyond existing resources, while bolstering its portfolio with new gold and lithium tenements and a successful $1M share placement.

Emerald Resources NL has reported record quarterly gold production at its Okvau Gold Mine, alongside significant resource expansions in Cambodia and Australia, positioning the company for robust growth.

GreenHy2 Limited reports a slight cash decline but strengthens its foothold in renewable energy with key partnerships and strategic pivots in hydrogen storage technology.

Dragon Mountain Gold Limited reports promising drilling results at its Avalon Project and prepares for further exploration at Cawse, supported by a successful $670,000 capital raise and strategic board appointment.

Gas2Grid navigates regulatory headwinds in Australia by pursuing new petroleum ventures in the Philippines while contesting a significant legal claim in France. The company’s ASX suspension persists as it seeks to restore compliance through fresh contracts.

Percheron Therapeutics has terminated its phase IIb avicursen trial for Duchenne muscular dystrophy after failing to meet efficacy endpoints, while securing $14.85 million in fresh capital to explore new therapeutic opportunities.